Supplemental Materials -to- cell reprogramming by forced...
Transcript of Supplemental Materials -to- cell reprogramming by forced...
1
Supplemental Materials
Context-specific -to- cell reprogramming by forced Pdx1 expression
Yu-Ping Yang, Fabrizio Thorel, Daniel F. Boyer, Pedro L. Herrera, and Christopher V.E. Wright
A. Supplemental Figures and Legends:
Supplemental Fig. 1 related to Fig. 1
Supplemental Fig. 2 related to Fig. 1 and 3
Supplemental Fig. 3 related to Fig. 2
Supplemental Fig. 4 related to Fig. 2 and 3
Supplemental Fig. 5 related to Fig. 2
Supplemental Fig. 6 related to Fig. 3
Supplemental Fig. 7 related to Fig. 3
Supplemental Fig. 8 related to Fig. 4
Supplemental Fig. 9 related to Fig. 4
Supplemental Fig. 10 related to Fig. 4
Supplemental Fig. 11 related to Fig. 1 and 4
B. Supplemental Materials and Methods:
Mouse strains
Morphometric analysis
Supplemental Table 1: List of antibodies used
Supplemental Table 2: Primers used in qRT-PCRs
C. Supplemental References
2
A. Supplemental Figures and Legends
Supplemental Fig. 1
Supplemental Fig. 1. Exogenous Pdx1 expression from Neurog3-expressing cells
(Neurog3Cre-Pdx1OE) selectively affects -cells but not other endocrine cells. (A-B’,
D-E’) Sst and Ppy expression at P1 and adult pancreas showed no obvious difference
between control and Neurog3Cre-Pdx1OE. No Sst-Gcg or Sst-Ins co-expression was
detected (A-B’). At P1, Ppy is expressed in a subset of Ins+ cells in both control and
Neurog3Cre-Pdx1OE (D,D’). However, no Ppy-Ins co-expression was detected in adult
pancreas (E,E’). (C,C’) Pdx1 expression was detected in Sst-expressing cells in control
and Neurog3Cre-Pdx1OE pancreas. (F,F’) Exogenous Pdx1 staining was found in
Neurog3Cre-Pdx1OE adult pancreas (arrows). Note no Gcg+ cells were detected in adult
Neurog3Cre-Pdx1OE pancreas. Ghr expression showed no alteration between P1
Neurog3Cre-Pdx1OE and control pancreas (data not shown).
3
Supplemental Fig. 2
Supplemental Fig. 2. Global glucose homeostasis of Neurog3Cre-Pdx1OE adults. (A) Intraperitoneal glucose tolerance test (IPGTT;
with overnight fasting) (2-3 months old; N=4 for each genotype) and (B) ad lib feeding glucose levels (9-11 months old) revealed no
significant difference, but slightly lower glucose levels.
4
Supplemental Fig. 3
Supplemental Fig. 3. Pooled number of Gcg-expressing and Ins-expressing cells at
key stages. No significant difference between control and Neurog3Cre-Pdx1OE is detected
at each stage (i.e. p>0.05 by one-factor ANOVA). N=3 per stage per genotype.
5
Supplemental Fig. 4
Supplemental Fig. 4. Quantitative RT-PCR analysis of key factors during endocrine
development and maturation at P1 and P12. Results of relative expression
(Neurog3Cre-Pdx1OE to control) were shown as CT±SEM. Asterisks denote significant
difference (p<0.05 determined by Student’s t-test) and those CT values are shown.
Neurog3Cre-Pdx1OE islets could not be consistently isolated, and such difficulties could be
caused by altered robustness (overall integrity, cell adhesion properties) in the absence of
peripheral -cells.
6
Supplemental Fig. 5
Supplemental Fig. 5. No significant difference in proliferation and cell death
between control and Neurog3Cre-Pdx1OE was detected. (A1-D2) Representative
pictures of BrdU (A1, A2) or Ki67 (B1-D2) staining of pancreatic islets at different
stages. (E) Proliferation index of -cells and -cells at different stages is shown in
percentage (%). The percentage was determined by proportion of BrdU+Gcg+ (or
7
Ki67+Gcg+) over total Gcg+ cells for proliferating -cells, and similarly BrdU+Ins+ (or
Ki67+Ins+) over total Ins+ for -cells. No obvious difference was detected between
control and Neurog3Cre-Pdx1OE. BrdU (100g per gram of mouse body weight) were
injected 1 hour prior to animal dissection. (F1-I2) Almost no TUNEL+ cells were found
in either genotype at different stages. (J) An internal positive control at intestine crypt
area shows several TUNEL+ cells.
8
Supplemental Fig. 6
Supplemental Fig. 6. Diminished Arx and MafB and ectopic Pax4 expression in
Neurog3Cre-Pdx1OE -cells at P12. (A,B) Decreased numbers of Arx+ cells were found
in Neurog3Cre-Pdx1OE pancreas, and some Ins+Arx+ cells were detected. (C,D) MafB
expression, normally in most Gcg-expressing cells (C), was not detected in all Gcg+ cells
in Neurog3Cre-Pdx1OE pancreas (arrows in D), suggesting repression of MafB by
exogenous Pdx1. (E,F) Pax4 expression, normally excluded from -cells (E), was
ectopically detected in Gcg-expressing cells in Neurog3Cre-Pdx1OE (arrows in F). Pax4
expression is detected in Ins+ cells in both control and Neurog3Cre-Pdx1OE.
9
Supplemental Fig. 7
Supplemental Fig. 7. Nkx6.1 and Glut2 expression appeared normal in Neurog3Cre-
Pdx1OE pancreas. (A,B) Nkx6.1 expression is detected in most Ins+ cells except for a
small residual number of Arx+Ins+ cells found rarely (arrows in B). (C,D) Glut2
expression is detected in most Ins+ cells except a few located at the islet periphery
(arrows and insets in D).
10
Supplemental Fig. 8
Supplemental Fig. 8. Absent MafB expression but maintained Arx expression in
GcgCre-Pdx1OE -cells. (A,B) MafB expression was not detected in most lineage-labeled
YFP+Pdx1HI -cells, while (C,D) Arx expression was maintained even in the presence of
ectopic Pdx1 expression. Asterisks in each panel denote representative cells that were
also shown in higher magnification in the separated channels. Loss of MafB and
maintenance of Arx were also detected in GcgrtTA/Cre-Pdx1OE lineage-labeled -cells (not
shown).
11
Supplemental Fig. 9
Supplemental Fig. 9. Exogenous Pdx1 in GcgCre-Pdx1OE does not induce Sst or Ppy
expression. (A,B) Sst expression is not detected in GcgCre-mediated YFP+ lineage-
labeled cells in either genotype. (C,D) In the control, Ppy was detected in a small
number of YFP+ cells (arrows in C), which is likely due to the lack of specificity of
available Ppy antibodies. Similarly in GcgCre-Pdx1OE, Ppy was also detected a small
proportion of YFP+ cells (either Pdx1- or Pdx1HI; arrows in D), while the great majority
of YFP+Pdx1HI cells were negative for Ppy immunodetection (e.g. inset and separated
channels in D).
12
Supplemental Fig. 10
Supplemental Fig. 10. Inefficient induction of Ins expression by forced Pdx1 expression in adult Gcg-expressing cells. (A)
Schematic presentation of an inducible genetic system to activate exogenous Pdx1 expression specifically in Gcg-expressing cells.
Gcg promoter driven rtTA (Gcg-rtTA) activates TetO-Cre responder in the presence of Doxycycline and thus drives Cre protein
13
expression, leading to Gcg cell-selective recombination of R26REYFP reporter and/or CAG-CAT-Pdx1 for exogenous Pdx1 expression.
(B) Doxycycline (DOX) treatment scheme. DOX was administered to 2-month-old adults for 2 weeks (“PULSE”), followed by 1
month of “CHASE” period. Analysis was therefore done on 3.5-month-old animals. (C-L) Exogenous Pdx1 expression is detected
in YFP+ lineage-labeled cells in GcgrtTA/Cre-Pdx1OE pancreas (J) but not in the control (E). Gcg expression was efficiently repressed
(H,I) but Ins expression was not induced (K).
14
Supplemental Fig. 11
Supplemental Fig. 11. Expression pattern of Set7/9 in Pdx1HI -cells adopts a -cell-
like nuclear pattern. (A,A’) At P14 control pancreas, Set 7/9 is expressed in the
cytoplasm of Gcg+ -cells (magenta cytoplasm) and is not detected in -cells (A). In
Neurog3Cre-Pdx1OE pancreas, Set7/9 is not detected in -cells or -cells (A’). (B,B’) In
adult, Set7/9 shows a cytoplasmic and nuclear pattern in-cells and a distinct nuclear
pattern in -cells (B; magenta cytoplasm with red nucleus). In Neurog3Cre-Pdx1OE adult,
no magenta cytoplasmic pattern of Set7/9 was detected, and most cells show a nuclear
pattern (B’). (C,C’) Set7/9 is detected in the cytoplasm and nucleus of GcgrtTA/Cre-
mediated lineage-labeled YFP+ -cells (the asterisk in C and separated channels; yellow
cytoplasm for YFP+ and cytoplasmic/nuclear Set7/9+). In YFP+Pdx1HI -cells of
GcgrtTA/Cre-Pdx1OE adult, Set7/9 is restricted in the nucleus (asterisk in C’ and separated
channels; absence of yellow cytoplasm pattern). Arrows in C’ denote two -cells that did
not go through recombination and show Set7/9 expression in cytoplasm and nucleus.
15
B. Supplemental Materials and Methods
Mouse strains
The following mouse lines were used and previously described: Neurgo3TgBAC-Cre
(Schonhoff et al., 2004), CAG-CAT-Pdx1 (Miyatsuka et al., 2003; Miyatsuka et al.,
2006), R26REYFP (Srinivas et al., 2001), GlucagonTgCre (Herrera, 2000), Glucagon-rtTA
(Thorel et al., 2010) and TetO-Cre (Perl et al., 2002).
Morphometric analysis
A systematic and broad analysis of the pancreas was undertaken at E16.5, P1, P7 and
P12, where every tenth pancreas section (5m each) of the whole pancreas was analyzed
completely, from three embryos or animals per genotype per stage. Sections were
Immunofluorescence-stained for Ins and Gcg, and the number of cells was determined by
manually counting every marker+ cell in each section. On average, ~2500 cells per
pancreas were counted for E16.5 and ~10,000 per pancreas for other postnatal stages
(also see Fig. S3). Statistical analysis was performed using single-factor ANOVA tests,
and significance determined with a p<0.05.
For the GcgCre-based studies, which used mice with a different compound genetic
background, Pdx1HIYFP+ cells from GcgCre-Pdx1OE pancreas (~400 cells from 5 animals)
or Pdx1-YFP+ cells from control (~1000 cells from 3 animals) were manually counted to
determine their Gcg and Ins expression status.
16
Supplemental Table 1. List of Antibodies used
Antibody Species Dilution Source
Arx Rabbit 1:1000* P. Collombat
FLAG Rabbit 1:1000* Thermo Scientific
GFP Chicken 1:2000 Aves
Glucagon Guinea pig 1:2000 Linco
Glut2 Rabbit 1:200 Alpha Diagnostic
Insulin c-peptide Goat 1:2000 Linco
MafA Rabbit 1:1000* Novus Biologicals
MafB Rabbit 1:10,000* Bethyl Laboratories
Neurog3 Goat 1:10,000* G. Gu
Nkx6.1 Rabbit 1:2000 BCBC
Pax4 Rabbit 1:1000* B. Sosa-Pineda
Pdx1 Guinea pig 1:20000 Self
Pancreatic polypeptide Guinea Pig 1:2000 Millipore
Somatostatin Goat 1:2000 Santa Cruz
*Tyramide signal amplification (Perkin Elmer) required.
17
Supplemental Table 2. Primers used in qRT-PCRs
Primer name Sequence
Arx CAGCCGCGCTGACCAGGAAA TGGTGGTGGCGGTGGAGGAA
Brn4 CGCACGTAGCCCACCACTCG CCGCTCACGGTGAAGCCTGG
GADPH AACTTTGGCATTGTGGAAGG GGATGCAGGGATGATGTTCT
Glucagon ACATCTCGTGCCAGTCACTT CGTTGGGTTACACAATGCT
Insulin CAGCAAGCAGGTCATTGTTT GGGACCACAAAGATGCTGTT
MafA CTCCTCCAAGCGCACGTGGT TTCAGCAAGGAGGAGGTCAT
MafB CAGGGTTTCTGAGCTTCTCC CCGGGTCTCTCTAACTCTGC
Nkx2.2 GTGCCCGGGCGGAGAAAGGTAT GGGGGTGTGCTGTCGGGTACT
Nkx6.1 ACTTGGCAGGACCAGAGAG GCGTGCTTCTTTCTCCACTT
Pax4 GAGAAAGAGTTTCAGCGTGGGCAG TGTCAGGTCCTGGGAAGCACCT
Pax6 AGCCCAGTATAAACGGGAGTGCC TCCCGGGATACCAACCAGGGC
Pdx1 GGAAGAGCCCAACCGCGTCC GGCGGGGCCGGGAGATGTAT
Pancreatic polypeptide ATGACCCAGGCGACTATGC TGTATCTGCGGAGCTGAGTT
Somatostatin CCCAGACTCCGTCAGTTTCT ACTTGGCCAGTTCCTGTTTC
18
C. Supplemental References Herrera, P.L. (2000). Adult insulin- and glucagon-producing cells differentiate from two
independent cell lineages. Development 127, 2317-2322. Miyatsuka, T., Kaneto, H., Kajimoto, Y., Hirota, S., Arakawa, Y., Fujitani, Y.,
Umayahara, Y., Watada, H., Yamasaki, Y., Magnuson, M.A., et al. (2003). Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis. Biochem Biophys Res Commun 310, 1017-1025.
Miyatsuka, T., Kaneto, H., Shiraiwa, T., Matsuoka, T.A., Yamamoto, K., Kato, K., Nakamura, Y., Akira, S., Takeda, K., Kajimoto, Y., et al. (2006). Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev 20, 1435-1440.
Perl, A.K., Wert, S.E., Nagy, A., Lobe, C.G., and Whitsett, J.A. (2002). Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci U S A 99, 10482-10487.
Schonhoff, S.E., Giel-Moloney, M., and Leiter, A.B. (2004). Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types. Dev Biol 270, 443-454.
Srinivas, S., Watanabe, T., Lin, C.S., William, C.M., Tanabe, Y., Jessell, T.M., and Costantini, F. (2001). Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1, 4.
Thorel, F., Nepote, V., Avril, I., Kohno, K., Desgraz, R., Chera, S., and Herrera, P.L. (2010). Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 464, 1149-1154.